Medical Equipment

Drug And Gene Delivery Devices Market Insights On Growth Drivers, Trends, And Opportunities

April 10, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Drug And Gene Delivery Devices Market Expected To Change From 2026 To 2030?

The market for drug and gene delivery devices has experienced significant expansion recently. This market is projected to expand from $0.67 billion in 2025 to $0.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. This historical expansion was influenced by aspects such as the scarcity of advanced delivery devices, a continued dependence on traditional administration routes, the early phases of gene therapy development, an expanding biologics pipeline, and increased funding for research collaborations.

The drug and gene delivery devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. The anticipated growth during this period stems from several factors, including technological progress in viral and non-viral vectors, the broadening scope of personalized medicine and gene therapy applications, a rise in regulatory approvals for novel delivery systems, increased acceptance of nanomedicine and LNPs, and the incorporation of digital monitoring and smart delivery platforms. Key trends foreseen for the forecast period encompass the expansion of targeted drug and gene therapies, a growing preference for nanoparticle-based delivery systems, greater utilization of viral vectors in gene therapy, the development of more injectable and non-invasive delivery techniques, and an emphasis on personalized medicine and controlled release technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp

Which Major Drivers Are Influencing The Expansion Of The Drug And Gene Delivery Devices Market?

The expanding use of gene therapy is anticipated to boost the growth of the drug and gene delivery devices market in the future. This medical approach involves introducing, removing, or modifying genetic material within a patient’s cells to manage or prevent illnesses. The demand for gene therapy is escalating because of its capacity to address the fundamental causes of genetic and chronic diseases, providing revolutionary treatment alternatives where traditional methods are inadequate. Drug and gene delivery devices play a crucial role in gene therapy by enabling accurate targeting and regulated release of therapeutic genes, thereby improving treatment effectiveness. For example, in January 2025, the American Society of Gene & Cell Therapy, a US-based non-profit organization, stated that in Q4 2024, pre-registration gene therapy programs saw their most significant increase in over a year, climbing by 83% compared to Q3 2024. Consequently, the growing adoption of gene therapy is fueling the expansion of the drug and gene delivery devices market.

How Is The Drug And Gene Delivery Devices Market Organized By Segment Classification?

The drug and gene delivery devices market covered in this report is segmented –

1) By Vector: Viral, Non-viral

2) By Method: In Situ, Ex Vivo

3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical

Subsegments:

1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors

2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.

Which Trends Are Shaping The Drug And Gene Delivery Devices Market?

Major companies operating in the drug and gene delivery devices market are focusing on developing advanced products, such as artificial intelligence (AI) technology, to gain a competitive edge. Artificial intelligence (AI) technology in drug delivery involves the application of AI techniques and algorithms to improve the efficiency, precision, and effectiveness of drug delivery systems. For instance, in December 2023, Envoya Inc., a US-based developer of polymer-based nanoparticles for targeted delivery, launched an innovative gene therapy drug delivery platform. This platform combines biopolymer-nanoparticles with artificial intelligence (AI) to address significant limitations in current gene therapy technologies, such as viral vectors and lipid nanoparticles. The platform aims to overcome the limitations of existing gene therapy delivery technologies, which have been restricted by safety concerns, limited payload capacities, and limited tissue targeting.

Who Are The Industry Participants Involved In The Drug And Gene Delivery Devices Market?

Major companies operating in the drug and gene delivery devices market are Medtronic plc, Moderna Inc., Halozyme Therapeutics Inc., Uniqure NV, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation, ICU Medical, Stevanato Group, Gerresheimer AG, Ypsomed, SHL Medical

Get The Full Drug And Gene Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/report/drug-and-gene-delivery-devices-global-market-report

Which Region Has The Greatest Market Share In The Drug And Gene Delivery Devices Market?

North America was the largest region in the drug and gene delivery devices market in 2025. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug And Gene Delivery Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=19404&type=smp

Browse Through More Reports Similar to the Global Drug And Gene Delivery Devices Market 2026, By The Business Research Company

Gastrointestinal Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Hematology Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795